# US 6,727,081 B2 · Microorganism isolated from chinese elm (Ulmus sp.) and process for preparing exopolysaccharides by employing the microorganism

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,081 B2
- Document ID: US6727081B2
- Status: Granted
- Kind: B2
- Application number: 09/921,013
- Filed: 2001-07-27
- Published: 2002-08-22
- Granted: 2004-04-27
- Earliest claimed: 2000-07-28
- Assignees: Samsung Electronics Co., Ltd.
- Inventors: Young Lyeol Yang; Young Joo Kim
- Web page: https://patentgrep.com/patent/US6727081B2

## CPC

- C12N 1/205: Bacterial isolates
- A61K 31/715: Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- C08B 37/00: Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof (cellulose D21; {microbiological processes C12P})
- C12P 19/04: Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
- C12R 2001/01: Bacteria or Actinomycetales {; using bacteria or Actinomycetales}
- Y10S 435/822: using bacteria or actinomycetales
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

The present invention relates to a novel Enterobacter sp. strain SSYL deposited under accession number KCTC 0687BP isolated from the root bark of Chinese elm, which produces immunostimulating exopolysaccharides with anticancer activity, a process for preparing the exopolysaccharides by fermenting the said microorganism in a culture medium, exopolysaccharides prepared by the process and their uses thereof. The exopolysaccharides of the invention have a molecular weight of 100,000 to 1,000,000 and consist of 40-75% of total sugar, 5-15% of total acidic sugar and 10-25% of total protein. The exopolysaccharides exhibits a high immunoenhancing activity in immune cell proliferation, direct mitogenicity and mixed lymphocyte reaction, and further a high anticancer activity in vivo by virtue of immunostimulation. Moreover, the production of the exopolysaccharides by fermentation of a microorganism, makes it possible to provide the exopolysaccharides with a uniform quality and mass production without destruction of the plant species. The exopolysaccharides of the subject invention have practical uses as an active ingredient for anticancer agents, immunoenhancers and foodstuffs.

## Claims

### Claim 1

A biologically pure culture of Enterobacter sp. having all of the identifying characteristics of Enterobacter sp. SSYL deposited under accession number KCTC 0687BP.

### Claim 2

A method of producing an exopolysaccharide, comprising:
providing cells of a biologically pure culture of Enterobacter sp. having all of the identifying characteristics of Enterobacter sp. SSYL deposited under accession number KCTC 0687BP;
culturing the cells in a medium culture so as to allow production of the exopolysaccharide.

### Claim 3 (depends on 2)

The method of claim 2, further comprising:
isolating the exopolysaccharide from a mixture comprising the culture medium, the cells and the exopolysaccharide.

### Claim 4 (depends on 2)

The method of claim 2, wherein the culture medium comprises a carbon source selected from the group consisting of glucose, sucrose, fructose, rhamnose, galactose, arbinose, mannitol, lactose, gluconate, xylose and mixtures thereof.

### Claim 5 (depends on 2)

The method of claim 2, wherein the culturing is performed at a temperature in a range from about 25° C. to about 38° C.

### Claim 6 (depends on 2)

The method of claim 2, wherein the culturing is performed under aeration at a flow rate in a range from about 0.1 vvm to about 1.5 vvm.

### Claim 7 (depends on 2)

The method of claim 2, wherein the culturing is performed under agitation at an agitation speed in a range from about 150 to about 500 rpm.

### Claim 8 (depends on 3)

The method of claim 3, wherein the isolation of the exopolysaccharide comprises:
removing cells from the mixture; and
dialyzing a resulting mixture so as to isolate the exopolysaccharide.

### Claim 9 (depends on 3)

The method of claim 3, wherein the isolation of the exopolysaccharide comprises:
centrifuging the culture mixture to obtain a supernatant;
precipitating a mixture comprising the exopolysaccharide;
dissolving the precipitate in a liquid; and
removing remaining cells.

### Claim 10 (depends on 8)

The method of claim 8, further comprising lyophilizing the dialyzed precipitate.

### Claim 11 (depends on 2)

A composition comprising the exopolysaccharide obtained by the method of claim 2.
